Interim Financials. The published interim results of the Company and its consolidated subsidiaries for the three months and six months ended June 30, 2020 have been prepared with all due care and attention (having regard to the fact that the results were made publicly available) and on accounting bases and assumptions consistent with those adopted in the preparation of the audited financial statements of the Company and its consolidated subsidiaries for the eleven month period ended December 31, 2019 and the corresponding interim results of the Company and its consolidated subsidiaries for the immediately preceding financial year as published in the Company’s Current Report on Form 8-K filed with the SEC on September 29, 2020, except as otherwise disclosed therein.
Appears in 6 contracts
Samples: Securities Purchase Agreement (Duggan Robert W), Securities Purchase Agreement (Zanganeh Maky), Securities Purchase Agreement (Summit Therapeutics Inc.)
Interim Financials. The published interim results of the Company and its consolidated subsidiaries for the three months ended September 30, 2020 and the three months and six months ended June 30, 2020 have been prepared with all due care and attention (having regard to the fact that the results were made publicly available) and on accounting bases and assumptions consistent with those adopted in the preparation of the audited financial statements of the Company and its consolidated subsidiaries for the eleven month period ended December 31, 2019 and the corresponding interim results of the Company and its consolidated subsidiaries for the immediately preceding financial year as published in the Company’s Quarterly Report on Form 10-Q filed with the SEC on November 16, 2020 and, with respect to the periods ended June 30, 2020, the Company’s Current Report on Form 8-K filed with the SEC on September 29, 2020, except as otherwise disclosed therein.
Appears in 1 contract
Interim Financials. The published interim results of the Company and its consolidated subsidiaries for the three months ended September 30, 2020 and the three months and six months ended June 30, 2020 have been prepared with all due care and attention (having regard to the fact that the results were made publicly available) and on accounting bases and assumptions consistent with those adopted in the preparation of the audited financial statements of the Company and its consolidated subsidiaries for the eleven month fiscal year period ended December 31, 2019 2020 and the corresponding interim results of the Company and its consolidated subsidiaries for the immediately preceding financial year as published in the Company’s Quarterly Report on Form 10-Q filed with the SEC on November 16, 2020 and, with respect to the periods ended June 30, 2020, the Company’s Current Report on Form 8-K filed with the SEC on September 29, 2020, except as otherwise disclosed therein.
Appears in 1 contract